GOSS 8-K 2026-07-14

Gossamer Bio, Inc. (GOSS) 8-K dated 2026-07-14 — accession 0001728117-26-000061. This URL is the filing, not the GOSS hub.

Gossamer Bio, Inc. (GOSS) is a biotechnology company listed on US.

Gossamer Bio, Inc. filed a 8-K on 2026-07-14. Accession 0001728117-26-000061.

Cached items: 5.02, 5.03, 5.07, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported GOSS revenue for 2026-06-30 was $26.2M. Net income was -$29.8M. Revenue was up 54.5% from 2026-03-31 to 2026-06-30. GOSS currently screens at market cap $47.0M.

Not investment advice. The GOSS SEC hub lists recent forms. The stock page is the research view.